#Lmsm
📣 THE PRELIMINARY PROGRAMME OF #ESHCART2027 IS AVAILABLE!
4th How I Manage CAR-T Therapies & Bispecific Antibodies for my Patients
Sept. 24-26, 2027|Stockholm, Sweden
Chairs: Michael Hudecek, Caron Jacobson, Marie José Kersten
To read it & for more info ➡ bit.ly/4ckiDZT
#ESHCONFERENCES #MMsm #Lmsm
November 13, 2026 at 11:59 AM
🤖 The meeting closed with Anthony Mato's keynote on AI in lymphoma care.

Thank you to all speakers, chairs and participants for three inspiring days in Prague. See you at the next ESH meeting! 👋

#ESHLYMPHOMA2026 #ESHCONFERENCES #LYMsm #Lmsm #ESHELEARNING
October 31, 2026 at 11:32 AM
Another lively round of Meet the Expert Sessions @ #ESHLYMPHOMA2026
Bjoern Chapuy, Oliver Weigert, Eric Jacobsen & Alison J. Moskowitz engaged in informal discussions with participants!
Chairs: Christian Buske, Michael Crump, Gilles Salles, Catherine Thieblemont
#ESHCONFERENCES #LYMsm #Lmsm
October 31, 2026 at 8:24 AM
🔄 Brunangelo Falini: vemurafenib + rituximab is the gold standard in R/R HCL.
🎤 Wolfram Klapper on transformation of indolent lymphomas.

Closed by a brief oral communication by Alessandro Mancini.

See you tomorrow morning! 👋

#ESHLYMPHOMA2026 #ESHCONFERENCES #LYMsm #Lmsm #ESHELEARNING
October 30, 2026 at 4:38 PM
Open & lively discussions during #ESHLYMPHOMA2026 Meet the Expert sessions 1st round with Laurence de Leval, Gloria Iacoboni and Andrew Davies .
Conference Chairs: Christian Buske, Michael Crump , Gilles Salles, Catherine Thieblemont
➡ bit.ly/42eJ3s6
#ESHCONFERENCES #ESHYOUNGREPORTERS #LYMsm #Lmsm
October 30, 2026 at 4:50 PM
⚖️ Debate 3 on CLL, chaired by Sarit Assouline: Barbara Eichhorst for fixed-duration vs Talha Munir for continuous or MRD-guided treatment. One of the key questions in CLL today.

#ESHLYMPHOMA2026 #ESHCONFERENCES #LYMsm #Lmsm #ESHELEARNING
October 30, 2026 at 2:36 PM
ESH Session V: non-follicular indolent B-cell lymphomas.
💬 Catherine Thieblemont: in R/R MZL, BTKi work in all subtypes; degraders, bispecifics and CAR-T are coming.
🎤 Anna Maria Frustaci: in R/R WM, cBTKi remain the main strategy. 🧵

#ESHLYMPHOMA2026 #ESHCONFERENCES #LYMsm #Lmsm #ESHELEARNING
October 30, 2026 at 4:38 PM
🔬 ESH Session IV: DLBCL, all case-based.
Bjoern Chapuy on elderly patients: first, do no harm.
Maria Gomes da Silva on first line DLBCL, including pitfalls like CNS prophylaxis and double-hit lymphoma. 🧵

#ESHLYMPHOMA2026 #ESHCONFERENCES #LYMsm #Lmsm #ESHELEARNING
October 30, 2026 at 11:38 AM
🔄 Marek Trněný: in R/R DLBCL, novel therapies (mainly T-cell engagers) improve survival; biopsy and sequencing matter.
🎤 Gloria Iacoboni: from transplant-eligible to CAR-T-eligible; CAR-T still favored over bispecifics in R/R LBCL.

#ESHLYMPHOMA2026 #ESHCONFERENCES #LYMsm #Lmsm #ESHELEARNING
October 30, 2026 at 11:38 AM
Good morning from Prague! Day 2 of ESH Lymphoma starts with three Meet the Expert sessions:
1️⃣ WHO5, ICC and beyond (Laurence de Leval)
2️⃣ Improving CAR-T outcomes (Gloria Iacoboni)
3️⃣ PET in B-cell lymphoma (Andrew Davies)

#ESHLYMPHOMA2026 #ESHCONFERENCES #LYMsm #Lmsm #ESHELEARNING
October 30, 2026 at 9:26 AM
🧬 Sara Ek: biological risk assessment (Ki-67, morphology, TP53 sequencing) belongs in the first treatment discussion, to identify high-risk MCLs early.

#ESHLYMPHOMA2026 #ESHCONFERENCES #LYMsm #Lmsm #ESHELEARNING
October 29, 2026 at 3:53 PM
⚖️ TOX & PRO roundtable: Gita Thanarajasingam (USA): max-grade AE reporting misses tolerability, so add longitudinal analysis and PROs.
🛡️ Tarec El-Galaly (Denmark): safety reporting lags behind novel therapies; PROs are the key.

#ESHLYMPHOMA2026 #ESHCONFERENCES #LYMsm #Lmsm #ESHELEARNING
October 29, 2026 at 5:43 PM
🔄 ESH late afternoon: Andrew Davies (UK) on ASCT in LBCL in 2026. ASCT is a niche (late, chemosensitive relapse), CAR-T is standard for early relapse and bispecifics are key after CAR-T. 🧵

#ESHLYMPHOMA2026 #ESHCONFERENCES #LYMsm #Lmsm #ESHELEARNING
October 29, 2026 at 5:43 PM
🔬 ESH Session II: T-cell lymphoma.
💬 Laurence de Leval on diagnosing nodal T-cell lymphoma entities 🧵
🗣️ Alison Moskowitz: BV-CH(E)P → ASCT still standard for CD30+ PTCL; the future is subtype-driven.

#ESHLYMPHOMA2026 #ESHCONFERENCES #LYMsm #Lmsm #ESHELEARNING
October 29, 2026 at 12:18 PM
Welcome to #ESHLYMPHOMA2026!
Stay tuned! #ESHYOUNGREPORTERS Diva Baggio &Prokop Vodička will provide regular updates on the conference!
Chairs: Christian Buske, Michael Crump, Gilles Salles, Catherine Thieblemont
October 29-31, 2026
➡ bit.ly/42eJ3s6
#ESHCONFERENCES #HAEMATOLOGY #LYMsm #Lmsm
October 29, 2026 at 8:28 AM
Good morning from Prague! ☀️ ESH Session I: Follicular Lymphoma.
Debate 1 🎤 Georg Hess vs Maria Gomes da Silva: do we need T-cell engagers in first-line FL? A fast-moving field, and the best treatment sequence is still open. 🧵

#ESHLYMPHOMA2026 #ESHCONFERENCES #LYMsm #Lmsm #ESHELEARNING
October 29, 2026 at 10:01 AM
Our Team is ready to welcome you in Prague for 5th How to Diagnose and Treat Lymphoma- #ESHLYMPHOMA2026.
Registration opens at 7:30 tomorrow!
Chairs: Christian Buske, Michael Crump, Gilles Salles, Catherine Thieblemont
October 29-31, 2026
➡ bit.ly/42eJ3s6
#ESHCONFERENCES #Haematology #LYMsm #Lmsm
October 28, 2026 at 5:14 PM
📣 PRESENTING THE MAIN TOPICS OF #ESHCART2027
4th How I Manage CAR-T Therapies & Bispecific Antibodies for my Patients
Sept. 24-26, 2027|Stockholm, Sweden
Chairs: Michael Hudecek, Caron Jacobson, Marie José Kersten
For more information ➡ bit.ly/4ckiDZT
#ESHCONFERENCES #HAEMATOLOGY #MMsm #Lmsm
October 14, 2026 at 8:46 AM
📣 #ESHLYMPHOMA2026 PROGRAMME HIGHLIGHT:
ROUNDTABLE 1 “TOX and PRO”
5th How to Diagnose and Treat Lymphoma
October 29-31, 2026 / Prague, Czech Republic
Chairs: Christian Buske, Michael Crump, Gilles Salles, Catherine Thieblemont
More info ➡ bit.ly/42eJ3s6
#ESHCONFERENCES #Haematology #MMsm #Lmsm
October 13, 2026 at 7:40 AM
📣 LESS THAN A MONTH BEFORE THE START OF #ESHLYMPHOMA2026
Don't delay, register now ➡ bit.ly/42eJ3s6
5th How to Diagnose and Treat Lymphoma
Chairs: Christian Buske, Michael Crump, Gilles Salles, Catherine Thieblemont
Oct. 29-31, 2026/Prague, Czech Republic
#ESHCONFERENCES #Haematology #LYMsm #Lmsm
October 6, 2026 at 10:39 AM
📣 ESHLYMPHOMA2026 PROGRAMME HIGHLIGHT:
SESSION 6 "Hodgkin lymphoma"
5th How to Diagnose and Treat Lymphoma
October 29-31, 2026 / Prague, Czech Republic
Chairs: Christian Buske, Michael Crump, Gilles Salles, Catherine Thieblemont
More info ➡ bit.ly/42eJ3s6
#ESHCONFERENCES #Haematology #MMsm #Lmsm
September 29, 2026 at 8:52 AM
Masepum (Video Oficial) - Aleks Syntek & Moncho Chavea by RUK-O
Estreno hace 8 horas 24 Sept 2026
www.youtube.com/watch?v=Lmsm...
Masepum (Video Oficial) - Aleks Syntek & Moncho Chavea by RUK-O
YouTube video by AleksSyntek.Oficial
www.youtube.com
September 25, 2026 at 5:03 AM
📣 DISCOVER THE LEARNING OBJECTIVES OF #ESHCART2027
4th How I Manage CAR-T Therapies & Bispecific Antibodies for my Patients
Sept. 24-26, 2027|Stockholm, Sweden
Chairs: Michael Hudecek, Caron Jacobson, Marie José Kersten
For more information ➡ bit.ly/4ckiDZT
#ESHCONFERENCES #HAEMATOLOGY #MMsm #Lmsm
September 15, 2026 at 3:06 PM
📣 PROGRAMME HIGHLIGHT OF #ESHLYMPHOMA2026
3 simultaneous Meet-the-Expert sessions
5th How to Diagnose and Treat Lymphoma
October 29-31, 2026 / Prague, Czech Republic
Chairs: Christian Buske, Michael Crump, Gilles Salles, Catherine Thieblemont
More info ➡ bit.ly/42eJ3s6
#ESHCONFERENCES #MMsm #Lmsm
September 15, 2026 at 8:26 AM